Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1976
DOI: 10.1001/archinte.1976.03630020048011
|View full text |Cite
|
Sign up to set email alerts
|

The Various Faces of Diabetes in the Young

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

1977
1977
2003
2003

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 50 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…Metabolic heterogeneity also exists in patients with chemical diabetes, and glucose intolerance in this situation may be associated with either insulin deficiency or insulin resistance [8,13]. Furthermore, it has been suggested that the patients with chemical diabetes who progress to insulin requiring diabetes may be the ones in whom insulin deficiency was the initial lesion [13][14][15]. A possible corollary to this observation is the fact [17] that 13 of 20 (65%) of recently diagnosed patients with relatively mild diabetes at the onset, and positive pancreatic islet cell antibodies, progressed to insulin-requiring diabetes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Metabolic heterogeneity also exists in patients with chemical diabetes, and glucose intolerance in this situation may be associated with either insulin deficiency or insulin resistance [8,13]. Furthermore, it has been suggested that the patients with chemical diabetes who progress to insulin requiring diabetes may be the ones in whom insulin deficiency was the initial lesion [13][14][15]. A possible corollary to this observation is the fact [17] that 13 of 20 (65%) of recently diagnosed patients with relatively mild diabetes at the onset, and positive pancreatic islet cell antibodies, progressed to insulin-requiring diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, it is obvious that the above conclusions are based upon generalizations concerning the metabolic characteristics of patients with chemical diabetes -specifically, that their mild glucose intolerance is associated with a loss of insulin sensitivity, without a primary defect in the insulin secretory response to oral glucose. It is apparent that not all patients with chemical diabetes share these metabolic characteristics [8,[13][14][15] and that the glucose intolerance of some proportion of patients with chemical diabetes is associated with a defect in the plasma insulin response to glucose. As such, these patients may well represent the individuals who progress to overt diabetes [8,10,[13][14][15].…”
Section: Discussionmentioning
confidence: 99%
“…By serial testing of young members of families with MODY, it can be demonstrated that there may be very slow progression from normal to impaired glucose tolerance; from impaired to diabetic glucose tolerance with normal fasting plasma glucose levels (up to 18 years); and no progression or very slow progression from that state to fasting hyperglycemia (up to 27 years) (Fajans 1982;1985;Fajans, Floyd, Tattersall, Williamson, Pek and Taylor 1976;Fajans, Cloutier and Crowther 1978). Other MODY have fasting hyperglycemia and/or more rapid progression from an early age (Fajans, Cloutier and Crowther 1978;Fajans 1985).…”
Section: Definition and Phenotypic Expression Of Modymentioning
confidence: 99%
“…Heterogeneity in diabetes mellitus is well recognized [1,2] as is reflected in the recent classification of the National Diabetes Data Group and World Health Organization [3,4]. Many patients with Type 2 diabetes are treated with insulin to control hyperglycaemia, and although they are not prone to spontaneous ketosis, ketoacidosis can occur in Type 2 diabetes with severe intercurrent illness or other stress.…”
mentioning
confidence: 99%